COVID-19 and rheumatology: is shielding really necessary?

Amani, Lisa; Warraich, Rabia; Patel, Nishil; Tahir, Hasan

Amani, Lisa; Warraich, Rabia; Patel, Nishil; Tahir, Hasan.

Amani L; Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
Warraich R; Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
Patel N; Department of Clinical Haematology, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
Tahir H; Department of Rheumatology and General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.

Br J Hosp Med (Lond) ; 81(6): 1-3, 2020 Jun 02.

Article in English | MEDLINE | ID: covidwho-614924

ABSTRACT

ABSTRACT

Rheumatology patients who are taking immunosuppressants are considered to be at 'high risk' from COVID-19, hence have been self-isolating or shielding. However, they may be protected from the features of hyperinflammation driven by a 'cytokine storm', so may have better clinical outcomes if infected. This editorial discusses whether it may not be necessary to advise these patients to shield.

Subject(s)

Coronavirus Infections/prevention & control; Immunosuppressive Agents/therapeutic use; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Rheumatic Diseases/drug therapy; Betacoronavirus; COVID-19; Coronavirus Infections/complications; Coronavirus Infections/immunology; Coronavirus Infections/physiopathology; Cytokine Release Syndrome/etiology; Cytokine Release Syndrome/immunology; Cytokine Release Syndrome/physiopathology; Health Behavior; Humans; Patient Education as Topic; Pneumonia, Viral/complications; Pneumonia, Viral/immunology; Pneumonia, Viral/physiopathology; Protective Factors; Rheumatology; Risk Factors; SARS-CoV-2; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Rheumatic Diseases / Coronavirus Infections / Pandemics / Immunosuppressive Agents Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Br J Hosp Med (Lond) Journal subject: Hospitals / Medicine Year: 2020 Document Type: Article Affiliation country: Hmed.2020.0284

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google